Government ❯ Regulation

Drug Policy

Narcotics Control Cannabis Legislation Controlled Substances Enforcement Cannabis Regulation FDA Chemical Regulations Kratom Health Regulations Kratom Legislation Opioid Crisis Response Customs Regulations Psychoactive Substances Substance Control Kratom Regulation Psychedelics Enforcement Agencies Psychedelic Research International Cooperation Law Enforcement Agencies Enforcement Strategies Customs Enforcement Psychedelic Substances Cannabidiol Products Hemp Products Hemp Regulation Marijuana Laws Opioid Regulation Illegal Drugs Non-Animal Testing Prescription Drugs Cannabis Laws Prescription Control Opioid Crisis Nitrous Oxide Monitoring Systems Lachgas Legislation Online Drug Sales State Laws Wildlife Conservation Research Chemicals Synthetic Substances Anti-Narcotics Operations Wildlife Regulations New Psychoactive Substances China Kratom Regulations Customs Youth Substance Abuse Cannabis Legalization Public Health Campaigns Public Safety Animal Welfare Laws Substance Regulation Psychedelic Regulation Legal Changes Synthetic Drugs Agricultural Regulations Controlled Substances Act

Two Ole Miss Students Identified After Packaged Kratom Found at Separate Death Scenes

Authorities say toxicology is being expedited while two independent death investigations continue with no confirmed cause.

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

U.S. Moves to Restrict Potent Kratom Alkaloid as States Expand Emergency Bans

Police Dismantle 555-Plant Cannabis Farm in Zorge, Two Held in Pretrial Custody

Purdue Pharma Shuts Down as $7.4 Billion Opioid Settlement Takes Effect

U.S. Kratom Poisoning Reports Hit Record in 2025, CDC Study Finds

CDC Report Finds Record U.S. Kratom Poison Calls in 2025

States Tighten Scrutiny of Synthetic 7‑OH as Missouri Probes, Ohio Moves to Regulate and Florida Defends Ban

Judge Approves Revised Purdue–Sackler Opioid Settlement Requiring Up To $7 Billion

Kratom Gummies Sicken Walker County 8th Graders at School

L.A. County Issues Warning After Three Deaths Tied to Synthetic Kratom Products

DeWine Asks Ohio Pharmacy Board to Classify All Kratom Compounds as Schedule I

Florida Moves to Ban Concentrated Kratom Alkaloid as Schedule I Substance

U.S. Regulators Move to Classify Potent Kratom Derivative as Schedule I Opioid

Elon Musk’s Negative Hair Drug Test Exposes SSN Slip, Raises Credibility Questions